These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cumulative Incidence of Infective Endocarditis in Patients with Congenital Heart Disease: A Nationwide, Case-Control Study Over Nine Decades. Snygg-Martin U; Giang KW; Dellborg M; Robertson J; Mandalenakis Z Clin Infect Dis; 2021 Oct; 73(8):1469-1475. PubMed ID: 34036324 [TBL] [Abstract][Full Text] [Related]
43. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Rushani D; Kaufman JS; Ionescu-Ittu R; Mackie AS; Pilote L; Therrien J; Marelli AJ Circulation; 2013 Sep; 128(13):1412-9. PubMed ID: 24060942 [TBL] [Abstract][Full Text] [Related]
44. Epidemiology and management of Staphylococcus Aureus infective endocarditis in adult patients with congenital heart disease: A single tertiary center experience. Arvanitaki A; Ibrahim W; Shore D; Diller GP; Li W; Rafiq I; Gatzoulis M; Montanaro C Int J Cardiol; 2022 Aug; 360():23-28. PubMed ID: 35500817 [TBL] [Abstract][Full Text] [Related]
45. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study. Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883 [TBL] [Abstract][Full Text] [Related]
46. Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Prosthetic or Bioprosthetic Heart Valves. Fauchier L; Pericart L; Bourguignon T; Genet T; Bisson A; Bernard A; Bernard L; Babuty D Am J Cardiol; 2017 Nov; 120(10):1884-1890. PubMed ID: 28917497 [TBL] [Abstract][Full Text] [Related]
47. Bioprosthetic pulmonary valve endocarditis: Incidence, risk factors, and clinical outcomes. Robichaud B; Hill G; Cohen S; Woods R; Earing M; Frommelt P; Ginde S Congenit Heart Dis; 2018 Sep; 13(5):734-739. PubMed ID: 30222901 [TBL] [Abstract][Full Text] [Related]
48. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis. Manne MB; Shrestha NK; Lytle BW; Nowicki ER; Blackstone E; Gordon SM; Pettersson G; Fraser TG Ann Thorac Surg; 2012 Feb; 93(2):489-93. PubMed ID: 22206953 [TBL] [Abstract][Full Text] [Related]
49. The changing landscape of infective endocarditis in South Africa. De Villiers MC; Viljoen CA; Manning K; Van der Westhuizen C; Seedat A; Rath M; Graham M; Ntsekhe M S Afr Med J; 2019 Jul; 109(8):592-596. PubMed ID: 31456555 [TBL] [Abstract][Full Text] [Related]
58. Infective endocarditis in adult patients with congenital heart disease. van Melle JP; Roos-Hesselink JW; Bansal M; Kamp O; Meshaal M; Pudich J; Luksic VR; Rodriguez-Alvarez R; Sadeghpour A; Hanzevacki JS; Sow R; Timóteo AT; Morgado MT; De Bonis M; Laroche C; Boersma E; Lancellotti P; Habib G; Int J Cardiol; 2023 Jan; 370():178-185. PubMed ID: 36273665 [TBL] [Abstract][Full Text] [Related]
59. Surgical management of infective endocarditis: an analysis of early and late outcomes. Pang PY; Sin YK; Lim CH; Tan TE; Lim SL; Chao VT; Chua YL Eur J Cardiothorac Surg; 2015 May; 47(5):826-32. PubMed ID: 25027271 [TBL] [Abstract][Full Text] [Related]